Evaluation of Liver Iron Deposition Status in Patients with Long-Term Blood Transfusion for Blood Disease by MRI T2 Technique

Jing-bo WANG,Feng GAO,Xiao-jin ZHANG,Hong-jiang WEI,Hao-dan DANG,Jie CHEN,Jie ZHAO,Jun-bao HE
DOI: https://doi.org/10.3760/cma.j.issn.1674-4756.2014.18.002
2014-01-01
Abstract:Objective To study the evaluation value of MRI T2 technique on liver iron deposi-tion status in patients with long-term blood transfusion for blood disease. Methods One hundred pa-tients with long-term blood transfusion for blood disease and 30 healthy persons were included in this study. The liver iron deposition status of 100 patients were divided into 5 groups according to their volume of blood transfusion. Serum ferritin levels of the patients with liver iron overload were measured and the correlation between the levels of SF and values of liver MRI T2 was analyzed. The patients who met the standard of iron chelation therapy received the treatment of deferoxamine. The levels of SF and values of liver MRI T2 were tested after 1 month and 3 months of treatment and the development of iron deposition was observed. Results The levels of SF of 82 patients with liver iron overload were significantly higher than those of healthy persons and were negatively related to the values of liver MRI T2( r= -0. 709 ,P=0. 00 ). Seventy-six patients received the treatment of deferoxamine and their levels of SF were significant-ly decreased( P﹤0. 05 ),and the values of liver MRI T2 were significantly increased( P﹤0. 05 )after 1 month and 3 months compared with the results before treatment. There was significant differences in the total reaction rate between 3 months and 1 month after treatment( P﹤0. 05 ). Conclusions The clinical evaluation value of MRI T2 technique on liver iron deposition status in patients with long-term blood transfusion for blood disease is high.
What problem does this paper attempt to address?